BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


PROGEN PHARMAC Add to My Watchlist (NSDQ: PGLA) 
Company Quote
 
Stock Data
Last Price 0.48 (11.18.09 8:10 PM EST)
Change (%)     - (-)
Volume -
Open -
Previous Close 0.48
Day High 0.48
Day Low 0.48
Bid 0.43 x 1000
Ask 0.47 x 500
 
Average Volume 4,122
Shares Outstanding 24.71M
Market Cap 11.9M
Year High 0.80
Year Low 0.30
Earnings Per Share N/A
P/E Ratio N/A
Dividend N/A
Yield N/A
Chart
 
Related Companies
Symbol Last Change (%)
ANX 0.10 +0.00 (+0.00)
LIXT 0.51 +0.00 (+0.00)
PLMO 0.27 -0.01 (-3.57%)
BLLSF 0.25 +0.00 (+0.00)
FEBTF 0.61 +0.00 (+0.00)
MZEI 0.09 +0.00 (+0.00)
GTHP 1.60 +0.40 (+33.33%)
News: PGLA
Wed, Jul 23, 2008
Unusual 11 Mid-Day Movers 7/23: PHLY, FED, COBR, RDN Higher; PGLA, PFBC, AEHR, ANAD Lower - StreetInsider
Wed, May 14, 2008
Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 - FOXBusiness.com
Mon, Sep 24, 2007
Progen Pharmaceuticals Phase 2 trial fails - SmallCapInvestor.com
StreetInsider.com Pre-Open Movers 09/24 - StreetInsider
Wed, May 23, 2007
Thomas Weisel Starts Progen Pharmaceuticals (PGLA) at Overweight - StreetInsider
Podcasts: PGLA
Thu, Aug 16, 2007
Micros Report 1 and 2 August 15, 2007 (video) - MN1
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
CLOSE WINDOW  
close window
E-mail Article to a Friend




CLOSE WINDOW  
close window
E-mail Article to a Friend